Semler Scientific Faces Class Actions for Alleged Investor Misleading Statements and DOJ Investigation

Semler Scientific Faces Class Action Lawsuits Over Alleged Misleading Statements

Semler Scientific, Inc. is currently confronting multiple class action lawsuits that allege violations of the Securities Exchange Act of 1934. These lawsuits are primarily focused on claims that Semler made false and misleading statements to its investors between March 10, 2021, and April 15, 2025. The core of the allegations revolves around the company's failure to disclose a Department of Justice (DOJ) investigation concerning potential violations of the False Claims Act. This lack of transparency is said to have resulted in materially misleading public statements, leading to substantial financial losses for investors once the truth regarding the investigation came to light.

The Schall Law Firm and DJS Law Group are two of the firms spearheading the legal actions against Semler Scientific. Both firms encourage affected shareholders to come forward and participate in the lawsuits, with deadlines for registration set for October 29, 2025. The firms emphasize that investors who purchased shares during the specified period may be eligible to recover their losses. They are offering consultations to discuss individual rights and the potential for lead plaintiff appointments, although participation does not necessitate such an appointment.

These legal challenges come at a crucial time for Semler Scientific, as the company seeks to navigate a competitive landscape in the medical technology sector. The ongoing investigations and the resulting lawsuits may not only affect investor confidence but also impact the company's reputation and operational strategies moving forward. As Semler works to address these issues, the outcome of the lawsuits could play a significant role in shaping its future trajectory and restoring trust among its stakeholders.